Craft

Probi

Stock Price

KR275

2024-10-29

Market Capitalization

KR3.2 B

2024-10-29

Revenue

KR627.7 M

FY, 2023

Probi Summary

Company Summary

Overview
Probi, a bioengineering company, researches, develops, manufactures, markets, and sells probiotics for food, health, and pharmaceutical companies. The Company operates in two segments: Consumer Healthcare and Functional Food. It conducts research primarily in the fields of digestive health, immune response, and nutrient absorption. The Company provides probiotics in the form of powder, capsules, tablets, and fruit juice drinks.
Type
Public
Status
Active
Founded
1991
HQ
Lund, SE | view all locations
Website
https://probi.com
Cybersecurity rating
ESG rating
50-59 out of 100|View all ESG data
Sectors

Key People

  • Jean-Yves Parisot

    Jean-Yves Parisot, Chairman of the Board

    • Irène Corthésy Malnoë

      Irène Corthésy Malnoë, Director

      • Charlotte Hansson

        Charlotte Hansson, Director

        • Jörn Andreas

          Jörn Andreas, Director

          LocationsView all

          4 locations detected

          • Lund, Skåne County HQ

            Sweden

          • Redmond, WA

            United States

            9609 153rd Ave NE

          • Singapore

            Singapore

            226 Pandan Loop

          • Lund, Skåne County

            Sweden

          Probi Financials

          Summary Financials

          Revenue (Q3, 2024)
          kr143.7M
          Gross profit (Q3, 2024)
          kr75.0M
          Net income (Q3, 2024)
          kr3.6M
          Cash (Q3, 2024)
          kr349.4M
          EBIT (Q3, 2024)
          kr3.0M
          Enterprise value
          $2.9B

          Footer menu